The Department of Health and Human Services issued preliminary rules regarding health insurance marketplaces that aim to deter fraudulent sign-ups for coverage. Experts say the agency’s action indicates a problem exists.
Muchos ven a los kits caseros negativos como una “tarjeta de libertad”. Pero puede haber errores, y también infecciones futuras.
Although at-home antigen testing remains a useful tool, experts warn it is often used inappropriately and can provide false confidence for people concerned about safety.
The American Medical Association and American Hospital Association are not arguing to halt the law that protects patients from unexpected bills from providers they didn’t know were outside their insurance network. Instead, they want to change the rules for the mediators who will settle the dispute between insurers and providers.
Medicare billing codes for audio-only follow-up check-ins lead to new reimbursement battles.
The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologists’ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.
Fueled by consumer frustration with high premiums and deductibles, two new offerings promise a means for consumers to take control of their health care costs. But experts say they pose risks.
Reports of waning effectiveness and mixed messages about booster shots fuel the politicization of vaccination.
¿Lo esencial? Vacunarse con cualquiera de las tres vacunas disponibles en los Estados Unidos disminuye la posibilidad de infectarse en primer lugar y reduce de manera significativa el riesgo de hospitalización o muerte si se contrae el coronavirus y se desarrolla covid-19.
New, often lower-cost plans capitalize on the convenience of telemedicine — and patients’ growing familiarity with it. But consumers should weigh costs and care options before enrolling in a “virtual-first” plan.